Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Ganirelix (Antagon) Peptide
GnRH antagonist for IVF cycles.
What is Ganirelix (Antagon)?
Ganirelix (Antagon) is a gnrh antagonist · reproductive peptide studied for ivf / assisted reproduction. Below is an educational overview of Ganirelix (Antagon) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Ganirelix Acetate, Orgalutran
Preventing premature ovulation during controlled ovarian stimulation in IVF.
A daily IVF injection that blocks the body's signal to release eggs early, so doctors can collect them at the right time.
- •Injection-site reactions
- •Abdominal pain
- •Headache
- •Hypersensitivity reactions
- •Ovarian hyperstimulation when combined with gonadotropins
- •Pregnancy
- •Known hypersensitivity to ganirelix or GnRH analogs
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Ganirelix (Antagon) Mechanism of Action
Decapeptide GnRH antagonist that rapidly suppresses pituitary LH/FSH release, used during ovarian stimulation to prevent premature ovulation.
Ganirelix (Antagon) Research Areas & Benefits
Ganirelix (Antagon) Dosage & Common Research Protocols
0.25 mg SC daily starting on stimulation day 5–6.
Protocols summarized for educational reference from published research. Not dosing guidance.
Ganirelix (Antagon) Studies & Cited Research
Ganirelix dose-finding study
Established 0.25 mg as optimal LH-suppressing dose.
Why we trust this source: Source not yet matched to our reputable list. Treat as background information only.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Ganirelix (Antagon) Side Effects & Safety Considerations
- •FDA-approved.
- •Generally well-tolerated; mild injection reactions.
Explore more peptides
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.